- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Heard at ISPOR: Debating the Benefits and Pitfalls of the QALY
During the ISPOR 2019 annual meeting, a panel discussion debated the good and the bad about the quality-adjusted life-year (QALY) from various perspectives. During this podcast, we sit down with 2 of the panelists to continue the QALY discussion.
During the ISPOR 2019 annual meeting, a panel discussion debated the good and the bad about the quality-adjusted life-year from various perspectives.
During this podcast, we sit down with Jennifer Bright, MPA, the executive director of the Innovation and Value Initiative, who moderated the discussion, and Lou Garrison, PhD, assistant director of the Pharmaceutical Outcomes Research and Policy Program at the University of Washington, who participated in the discussion.
You may need to log in to the website to access this podcast.
Listen above or through one of these podcast services:
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
